The Vascutek Anaconda™ Stent Graft System for repair of Abdominal Aortic Aneurysms (AAA) is the subject of this observational study. 180 patients will be implanted with the Anaconda™ Stent Graft System and will be followed-up annually for 5 years post-implant. The study will satisfy the requirements of the French National Authority for Health (Haute Autorité de santé) and the data collected will be used for reimbursement renewal.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Overall mortality rate
Timeframe: Post-op (within 30 days), 6 months, 12 months and then annually up to 5 years
Mortality rate related to rupture of the aneurysm and relationship to the stent
Timeframe: Post-op (within 30 days), 6 months, 12 months and then annually up to 5 years
Change in diameter of the aneurysm
Timeframe: Post-op (within 30 days), 6 months, 12 months and then annually up to 5 years
Rate of Type I, II and III endoleaks
Timeframe: Post-op (within 30 days), 6 months, 12 months and then annually up to 5 years
Surgical conversion rate
Timeframe: Post-op (within 30 days), 6 months, 12 months and then annually up to 5 years
Rate of endovascular or surgical revisions
Timeframe: Post-op (within 30 days), 6 months, 12 months and then annually up to 5 years